283 related articles for article (PubMed ID: 35089354)
1. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
Marcum ZA; Cohen JB; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Williamson J; Pajewski NM; Bress AP;
JAMA Netw Open; 2022 Jan; 5(1):e2145319. PubMed ID: 35089354
[TBL] [Abstract][Full Text] [Related]
2. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
Cohen JB; Marcum ZA; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Scharfstein D; Williamson J; Pajewski NM; Bress AP;
JAMA Netw Open; 2022 Jul; 5(7):e2220680. PubMed ID: 35834254
[TBL] [Abstract][Full Text] [Related]
3. Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries.
Marcum ZA; Gabriel N; Bress AP; Hernandez I
JAMA Netw Open; 2023 Jan; 6(1):e2249370. PubMed ID: 36598787
[TBL] [Abstract][Full Text] [Related]
4. Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents.
Marcum ZA; Li Y; Lee SJ; Steinman MA; Graham L; Jing B; Fung K; Peralta CA; Odden MC
J Alzheimers Dis; 2022; 86(3):1149-1158. PubMed ID: 35147539
[TBL] [Abstract][Full Text] [Related]
5. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
[TBL] [Abstract][Full Text] [Related]
6. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
[TBL] [Abstract][Full Text] [Related]
7. Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial.
van Dalen JW; Marcum ZA; Gray SL; Barthold D; Moll van Charante EP; van Gool WA; Crane PK; Larson EB; Richard E
Neurology; 2021 Jan; 96(1):e67-e80. PubMed ID: 33154085
[TBL] [Abstract][Full Text] [Related]
8. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
Hughes D; Judge C; Murphy R; Loughlin E; Costello M; Whiteley W; Bosch J; O'Donnell MJ; Canavan M
JAMA; 2020 May; 323(19):1934-1944. PubMed ID: 32427305
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.
Liampas I; Hatzimanolis A; Siokas V; Yannakoulia M; Kosmidis MH; Sakka P; Hadjigeorgiou GM; Scarmeas N; Dardiotis E
J Alzheimers Dis; 2022; 89(2):709-719. PubMed ID: 35912747
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study.
Gaussoin SA; Pajewski NM; Chelune G; Cleveland ML; Crowe MG; Launer LJ; Lerner AJ; Martindale-Adams J; Nichols LO; Ogrocki PK; Sachs BC; Sink KM; Supiano MA; Wadley VG; Wilson VM; Wright CB; Williamson JD; Reboussin DM; Rapp SR
J Am Geriatr Soc; 2022 May; 70(5):1384-1393. PubMed ID: 34826341
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study.
Goveas JS; Hogan PE; Kotchen JM; Smoller JW; Denburg NL; Manson JE; Tummala A; Mysiw WJ; Ockene JK; Woods NF; Espeland MA; Wassertheil-Smoller S
Int Psychogeriatr; 2012 Aug; 24(8):1252-64. PubMed ID: 22301077
[TBL] [Abstract][Full Text] [Related]
13. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
[TBL] [Abstract][Full Text] [Related]
14. Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project.
Manly JJ; Jones RN; Langa KM; Ryan LH; Levine DA; McCammon R; Heeringa SG; Weir D
JAMA Neurol; 2022 Dec; 79(12):1242-1249. PubMed ID: 36279130
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
[TBL] [Abstract][Full Text] [Related]
16. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
Kovács T
Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
[TBL] [Abstract][Full Text] [Related]
17. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
Kurella Tamura M; Gaussoin SA; Pajewski NM; Chelune GJ; Freedman BI; Gure TR; Haley WE; Killeen AA; Oparil S; Rapp SR; Rifkin DE; Supiano M; Williamson JD; Weiner DE;
J Am Soc Nephrol; 2020 Sep; 31(9):2122-2132. PubMed ID: 32591439
[TBL] [Abstract][Full Text] [Related]
18. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
[TBL] [Abstract][Full Text] [Related]
19. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
20. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study.
Agnew-Blais JC; Wassertheil-Smoller S; Kang JH; Hogan PE; Coker LH; Snetselaar LG; Smoller JW
J Acad Nutr Diet; 2015 Feb; 115(2):231-241. PubMed ID: 25201007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
